Beyond Air Inc (XAIR)
0.53
+0.05
(+9.71%)
USD |
NASDAQ |
Nov 14, 16:00
0.58
+0.05
(+9.43%)
After-Hours: 04:49
Beyond Air Research and Development Expense (Quarterly): 6.009M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.009M |
| March 31, 2024 | 5.699M |
| December 31, 2023 | 6.838M |
| September 30, 2023 | 7.13M |
| June 30, 2023 | 4.695M |
| March 31, 2023 | 4.131M |
| December 31, 2022 | 5.00M |
| September 30, 2022 | 4.452M |
| June 30, 2022 | 3.226M |
| March 31, 2022 | 3.711M |
| December 31, 2021 | 2.543M |
| September 30, 2021 | 2.807M |
| June 30, 2021 | 2.741M |
| March 31, 2021 | 1.845M |
| December 31, 2020 | 3.294M |
| Date | Value |
|---|---|
| September 30, 2020 | 3.147M |
| June 30, 2020 | 4.332M |
| March 31, 2020 | 2.895M |
| December 31, 2019 | 2.581M |
| September 30, 2019 | 2.85M |
| June 30, 2019 | 2.324M |
| March 31, 2019 | 1.630M |
| December 31, 2018 | 0.5867M |
| September 30, 2018 | 0.648M |
| June 30, 2018 | 1.063M |
| March 31, 2018 | 1.637M |
| December 31, 2017 | 1.215M |
| September 30, 2017 | 1.193M |
| June 30, 2017 | 0.591M |
| March 31, 2017 | 1.439M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.845M
Minimum
Mar 2021
7.13M
Maximum
Sep 2023
4.057M
Average
3.711M
Median
Mar 2022
Research and Development Expense (Quarterly) Benchmarks
| NeuroOne Medical Technologies Corp | 1.195M |
| SINTX Technologies Inc | 1.677M |
| Nutriband Inc | 0.774M |
| enVVeno Medical Corp | 2.859M |
| CVRx Inc | 2.504M |